Rybelsus vs. Jardiance
See how Rybelsus and Jardiance compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Rybelsus is an oral GLP-1 receptor agonist that lowers blood sugar and cuts cardiovascular risk, taken as a daily pill on an empty stomach.
Jardiance is an oral SGLT2 inhibitor with a simpler once-daily dose that also protects the heart and kidneys, including in heart failure.
Both treat type 2 diabetes but work through completely different mechanisms, so a doctor may combine them rather than choose one over the other.
Rybelsus vs. Jardiance Drug Summary
Rybelsus
Rybelsus (semaglutide) is an oral GLP-1 receptor agonist used to control blood sugar in type 2 diabetes and to lower the risk of major cardiovascular events in patients with established heart disease. It is taken as a tablet once a day on an empty stomach, starting at 3 mg and increasing over about two months to a 14 mg maintenance dose.
Jardiance
Jardiance (empagliflozin) is an oral SGLT2 inhibitor used to control blood sugar in type 2 diabetes and to reduce cardiovascular death, heart failure hospitalization, and kidney disease progression. It is taken as a single daily tablet at 10 mg, with an option to increase to 25 mg if more blood sugar control is needed.
Rybelsus vs. Jardiance Side Effects
Rybelsus
Jardiance
Rybelsus vs. Jardiance Dosage
Rybelsus
Jardiance
| STAGE | DOSE | WHEN |
| Starting dose | 3 mg once daily | Days 1-30 |
| Maximum dose | 14 mg once daily | Day 61 onward |
| Dose changes | 2 increases | Every 30 days |
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Rybelsus
| STAGE | DOSE | WHEN |
| Starting dose | 3 mg once daily | Days 1-30 |
| Maximum dose | 14 mg once daily | Day 61 onward |
| Dose changes | 2 increases | Every 30 days |
Jardiance
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Rybelsus vs. Jardiance Indications
Rybelsus
Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of heart attack, stroke, or cardiovascular death in those with existing heart disease. It is not approved for type 1 diabetes or for chronic weight management, though some doctors prescribe it off-label for weight loss.
Blood sugar control in type 2 diabetes
Cardiovascular risk reduction with known heart disease
Off-label: weight loss in people without diabetes
Jardiance
Jardiance is FDA-approved for blood sugar control in adults and children 10 and older with type 2 diabetes, and it carries broader heart and kidney approvals than Rybelsus. It reduces cardiovascular death risk, heart failure hospitalization regardless of ejection fraction, and the progression of chronic kidney disease.
Blood sugar control in type 2 diabetes, including pediatric patients
Cardiovascular death risk reduction with heart disease
Heart failure hospitalization and death risk reduction
Rybelsus vs. Jardiance Pros and Cons
Rybelsus
Rybelsus offers the added benefit of appetite reduction and meaningful weight loss alongside blood sugar control, plus proven cardiovascular protection. It requires a strict routine of taking it on an empty stomach with a small amount of water and waiting 30 minutes before eating.
Pros
Often leads to noticeable weight loss as a side benefit
First and only oral GLP-1 approved for type 2 diabetes
Reduces cardiovascular event risk in heart disease patients
Cons
Typically costs $998 to $1,029 per month without insurance
GI side effects like nausea and vomiting are common
Carries a boxed warning for thyroid C-cell tumor risk
Must be taken on an empty stomach with strict timing
Jardiance
Jardiance has a simpler dosing routine with no titration and no food or timing restrictions, and its approvals extend into heart failure and chronic kidney disease care. Its main risks involve genital infections and dehydration-related drops in blood pressure rather than digestive side effects.
Pros
No titration schedule, effective from the first dose
Typically costs $350 to $620 per month without insurance
Approved for heart failure regardless of ejection fraction
Cons
Raises risk of genital yeast and urinary tract infections
Can cause diabetic ketoacidosis even with normal blood sugar
Risk of dehydration and low blood pressure, especially in older adults
Not associated with meaningful weight loss
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.